Small Molecules
27 February 2014
Cubist Announces EMA Acceptance of Tedizolid Marketing Authorization Application for Review27 February 2014
Ignyta Announces Submission of IND for RXDX-10127 February 2014
AtheroNova Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, a Potential Treatment for Atherosclerosis27 February 2014
Forest Laboratories Submits a New Drug Application for Nebivolol and Valsartan Combination in Hypertension26 February 2014
Clinical trials initiated for a new molecule jointly identified by IRIC and Bristol-Myers Squibb26 February 2014
Altheus Therapeutics completes treatment portion of ZA201, a Phase 2 trial of Zoenasa for ulcerative colitis26 February 2014
Mirvaso® (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission25 February 2014
Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-471825 February 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)25 February 2014
Aerie Pharmaceuticals Announces Study Results Supporting Additional Mechanism of Action for Lead Glaucoma Drug Candidate AR-1332425 February 2014
Iroko Pharmaceuticals Receives FDA Approval for TIVORBEX25 February 2014
Synchroneuron Announces First Patient Dosed in Phase 2 Tardive Dyskinesia Clinical Trial25 February 2014
BioCryst Announces Peramivir NDA Acceptance by the FDA24 February 2014
IntelGenx Achieves Positive Bioequivalence Results for Erectile Dysfunction VersaFilm(TM) Tadalafil Product22 February 2014
BTG announces Varithena™ data demonstrating continued improvement at one year at the American Venous Forum Annual Meeting22 February 2014
U.S. Food and Drug Administration Approves KALYDECO™ (ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis21 February 2014
GSK receives positive CHMP opinion for Incruse® (umeclidinium) for the treatment of COPD21 February 2014
Janssen Initiates CREDENCE Study in Patients with Type 2 Diabetes and Diabetic NephropathyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports